MENU
AAPG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ascentage Pharma Group (AAPG) Ownership - Who owns Ascentage Pharma Group?
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.12B
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
1.81 USD as % of share price
Fundamentals
AAPG
Capitalization
3.12B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.81%
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
84.75
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
N/A
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
5.15M
Shares Outstanding - Current
87.1M
Total Liabilities
N/A
Total Volume MTD
N/A
Value
-1
Gain YTD
N/A
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information